Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis

Human Gene Therapy

Volumn 20, Issue 2, 2009, Pages 97-101

  Wehling, Peter ^a,b,c   Reinecke, Julio ^c   Baltzer, Axel W A ^a,d   Granrath, Markus ^a,d   Schulitz, Klaus P ^a   Schultz, Carl ^c   Krauspe, Rüdiger ^a   Whiteside, Theresa W ^e   Elder, Elaine ^e   Ghivizzani, Steven C ^f   Robbins, Paul D ^e   Evans, Christopher H ^g,h  

^a Department of Orthopedic Surgery   (Germany)

^b Center for Molecular Medicine   (Germany)

^c Orthogen AG   (Germany)

^d Zentrum für Molekulare Orthopädie Gemeinschaftspraxis Königsallee   (Germany)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h Center for Advanced Orthopedic Studies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; COMPLEMENTARY DNA; DICLOFENAC; DIPYRONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MELOXICAM; METHOTREXATE; METHYLPREDNISOLONE; NEUROFENAC; PLACEBO; PREDNISOLONE; RNA; STEROID; STROMELYSIN; TRAMADOL;

ADULT; ARTHRITIS; ARTICLE; CASE REPORT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; METACARPOPHALANGEAL JOINT; NONHUMAN; PAIN ASSESSMENT; RETROVIRUS; RHEUMATOID ARTHRITIS; SYNOVECTOMY; SYNOVIOCYTE; SYNOVIUM; TRANSGENE; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; ARTHRITIS, RHEUMATOID; BLOTTING, NORTHERN; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASES; METACARPOPHALANGEAL JOINT; MIDDLE AGED; PAIN; RETROVIRIDAE; TIME FACTORS; TREATMENT OUTCOME;

EID: 58849159153     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.075     Document Type: Article

References (22)

1. Abe, M., Tanaka, Y., Saito, K., Shirakawa, F., Koyama, Y., Goto, S., and Eto, S. (1997). Regulation of interleukin (IL)-1β gene transcription induced by IL-1β in rheumatoid synovial fibroblast-like cells, E11, transformed with simian virus 40 large T antigen. J. Rheumatol. 24, 420-429.
2. Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., Healey, L.A., Kaplan, S.R., Liang, M.H., Luthra, H.S., Medsger, T.A., Jr., Mitchell, D.M., Neustadt, D.H., Pinals, R.S., Schaller, J.G., Sharp, J.T., Wilder, R.L., and Hunder, G.G. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315-324.
3. Bandara, G., Robbins, P.D., Georgescu, H.I., Mueller, G.M., Glorioso, J.C., and Evans, C.H. (1992). Gene transfer to synoviocytes: Prospects for gene treatment of arthritis. DNA Cell Biol. 11, 227-231.
4. Bandara, G., Mueller, G.M., Galea-Lauri, J., Tindal, M.H., Georgescu, H.I., Suchanek, M.K., Hung, G.L., Glorioso, J.C., Robbins, P.D., and Evans, C.H. (1993). Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc. Natl. Acad. Sci. U.S.A. 90, 10764-10768.
5. Del Vecchio, M.A., Georgescu, H.I., McCormack, J.E., Robbins, P.D., and Evans, C.H. (2001). Approaches to enhancing the retroviral transduction of human synoviocytes. Arthritis Res. 3, 259-263.
6. Evans, C.H., Robbins, P.D., Ghivizzani, S.C., Herndon, J.H., Kang, R., Bahnson, A.B., Barranger, J.A., Elders, E.M., Gay, S., Tomaino, M.M., Wasko, M.C., Watkins, S.C., Whiteside, T.L., Glorioso, J.C., Lotze, M.T., and Wright, T.M. (1996). Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum. Gene Ther. 7, 1261-1280.
7. Evans, C.H., Gouze, J.N., Gouze, E., Robbins, P.D., and Ghivizzani, S.C. (2004). Osteoarthritis gene therapy. Gene Ther. 11, 379-389.
8. Evans, C.H., Robbins, P.D., Ghivizzani, S.C., Wasko, M.C., Tomaino, M.M., Kang, R., Muzzonigro, T.A., Vogt, M., Elder, E.M., Whiteside, T.L., Watkins, S.C., and Herndon, J.H. (2005). Gene transfer to human joints: Progress toward a gene therapy of arthritis. Proc. Natl. Acad. Sci. U.S.A. 102, 8698-8703.
9. Evans, C.H., Ghivizzani, S.C., and Robbins, P.D. (2006a). Arthritis gene therapy: What next? Arthritis Rheum. 54, 1714-1729.
10. Evans, C.H., Ghivizzani, S.C., and Robbins, P.D. (2006b). Will arthritis gene therapy become a clinical reality? Nat. Clin. Pract. 2, 344-345.
11. Evans, C.H., Ghivizzani, S.C., Wehling, P., and Robbins, P.D. (2006c). Gene Therapy with the interleukin-1 receptor antagonist for the treatment of arthritis. Future Rheumatol. 1, 173-178.
12. Evans, C.H., Ghivizzani, S.C., and Robbins, P.D. (2008). Arthritis gene therapy's first death. Arthritis Res. Ther. 10, 110-119.
13. Felson, D.T., Anderson, J.J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L.M., Lightfoot, R., Jr., Paulus, H., Strand, V., Tugwell, P., Weinblatt, M., Williams, H.J., Wolfe, F., and Kieszak, S. (1995). American College of Rheumatology: Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 38, 727-735.
14. Frisbie, D.D., Ghivizzani, S.C., Robbins, P.D., Evans, C.H., and McIlwraith, C.W. (2002). Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther. 9, 12-20.
15. Gaston-Johansson, F., and Gustafsson, M. (1990). Rheumatoid arthritis: Determination of pain characteristics and comparison of RAI and VAS in its measurement. Pain 41, 35-40.
16. Ghivizzani, S.C., Lechman, E.R., Kang, R., Tio, C., Kolls, J., Evans, C.H., and Robbins, P.D. (1998). Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc. Natl. Acad. Sci. U.S.A. 95, 4613-4618.
17. Gouze, E., Gouze, J.N., Palmer, G.D., Pilapil, C., Evans, C.H., and Ghivizzani, S.C. (2007). Transgene persistence and cell turnover in the diarthrodial joint: Implications for gene therapy of chronic joint diseases. Mol. Ther. 15, 1114-1120.
18. Jeong, J.G., Kim, J.M., Cho, H., Hahn, W., Yu, S.S., and Kim, S. (2004). Effects of IL-1b on gene expression in human rheumatoid synovial fibroblasts. Biochem. Biophys. Res. Commun. 324, 3-7.
19. Kohn, D.B., Sadelain, M., and Glorioso, J.C. (2003). Occurrence of leukaemia following gene therapy of X-linked SCID. Nat. Rev. Cancer 3, 477-488.
20. Otani, K., Nita, I., Macaulay, W., Georgescu, H.I., Robbins, P.D., and Evans, C.H. (1996). Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J. Immunol. 156, 3558-3562.
21. Pelletier, J.P., Caron, J.P., Evans, C., Robbins, P.D., Georgescu, H.I., Jovanovic, D., Fernandes, J.C., and Martel-Pelletier, J. (1997). In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum. 40, 1012-1019.
22. Smolen, J.S., Aletaha, D., Koeller, M., Weisman, M.H., and Emery, P. (2007). New therapies for treatment of rheumatoid arthritis. Lancet 370, 1861-1864.